Overactive Bladder

Potential Role of Monocyte Chemoattractant Protein-1 in Monitoring Disease Progression and Response to Treatment in Overactive Bladder Patients. January 10, 2021

Clinical Manifestations of Overactive Bladder With Migraine as a Comorbidity: A Prospective Cross-Sectional Study. January 10, 2021

Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men. January 10, 2021

Meta-Analysis of the Efficacy and Safety of Imidafenacin for Overactive Bladder Induced by Benign Prostatic Hyperplasia in Men Receiving Alpha-Blocker Therapy. January 10, 2021

GEMTESA® (vibegron) Receives U.S. FDA Approval for the Treatment of Patients with Overactive Bladder (OAB) January 4, 2021

Adverse Childhood Experiences in Women With Overactive Bladder or Interstitial Cystitis/Bladder Pain Syndrome. January 3, 2021

Detrusor Overactivity May Be a Prognostic Factor for Better Response to Combination Therapy Over Monotherapy in Male Patients With Benign Prostatic Enlargement and Storage Lower Urinary Tract Symptoms. January 3, 2021

Persistence in percutaneous tibial nerve stimulation treatment for overactive bladder syndrome is best predicted by patient global impression of improvement rather than symptom-specific improvement. January 3, 2021

The Effect of Social Determinants of Health on Overactive Bladder Symptom Severity. December 27, 2020

[Follow-up and evaluation of non-neurogenic OAB treatments]. December 27, 2020

The impact of overactive bladder on health-related quality of life in Korea: based on the results of a Korean Community Health Survey. December 27, 2020

Do Older Adults with Overactive Bladder Demonstrate Impaired Executive Function Compared to Their Peers Without OAB? December 20, 2020

Vibegron Improves Quality-of-Life Measures in Patients With Overactive Bladder: Patient-Reported Outcomes From the EMPOWUR Study. December 20, 2020

Evaluating the Quality of Overactive Bladder Patient Education Material on YouTube: A Pilot Study Using the Patient Education Materials Assessment Tool. December 13, 2020

Urodynamic predictors of de novo overactive bladder after single-incision sling. December 13, 2020

A retrospective longitudinal evaluation of new overactive bladder patients in an FPMRS urologist practice: Are patients following up and utilizing third-line therapies? December 13, 2020

Which Drugs Are Best for Overactive Bladder? From Patients' Expectations to Physicians' Decisions. December 6, 2020

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity. December 6, 2020

Mirabegron Add-On Therapy to Tamsulosin in Men with Overactive Bladder: Post Hoc Analyses of Efficacy from the MATCH Study. November 29, 2020

[First-line treatment for non-neurogenic overactive bladder]. November 29, 2020

Page 1 of 92